These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 19217269)

  • 21. Phagocytic processing of antigens for presentation by class II major histocompatibility complex molecules.
    Ramachandra L; Noss E; Boom WH; Harding CV
    Cell Microbiol; 1999 Nov; 1(3):205-14. PubMed ID: 11207553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On regulation of phagosome maturation and antigen presentation.
    Blander JM; Medzhitov R
    Nat Immunol; 2006 Oct; 7(10):1029-35. PubMed ID: 16985500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of phagosome maturation by mycobacteria does not interfere with presentation of mycobacterial antigens by MHC molecules.
    Majlessi L; Combaluzier B; Albrecht I; Garcia JE; Nouze C; Pieters J; Leclerc C
    J Immunol; 2007 Aug; 179(3):1825-33. PubMed ID: 17641049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The comings and goings of MHC class I molecules herald a new dawn in cross-presentation.
    Blander JM
    Immunol Rev; 2016 Jul; 272(1):65-79. PubMed ID: 27319343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TAP mediates import of Mycobacterium tuberculosis-derived peptides into phagosomes and facilitates loading onto HLA-I.
    Harriff MJ; Burgdorf S; Kurts C; Wiertz EJ; Lewinsohn DA; Lewinsohn DM
    PLoS One; 2013; 8(11):e79571. PubMed ID: 24244525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells.
    Savina A; Jancic C; Hugues S; Guermonprez P; Vargas P; Moura IC; Lennon-Duménil AM; Seabra MC; Raposo G; Amigorena S
    Cell; 2006 Jul; 126(1):205-18. PubMed ID: 16839887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NADPH oxidase modifies patterns of MHC class II-restricted epitopic repertoires through redox control of antigen processing.
    Allan ER; Tailor P; Balce DR; Pirzadeh P; McKenna NT; Renaux B; Warren AL; Jirik FR; Yates RM
    J Immunol; 2014 Jun; 192(11):4989-5001. PubMed ID: 24778444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells.
    Guermonprez P; Saveanu L; Kleijmeer M; Davoust J; Van Endert P; Amigorena S
    Nature; 2003 Sep; 425(6956):397-402. PubMed ID: 14508489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recruitment of Rab27a to phagosomes controls microbial antigen cross-presentation by dendritic cells.
    Kim SH; Visser A; Cruijsen C; van der Velden AW; Boes M
    Infect Immun; 2008 Nov; 76(11):5373-80. PubMed ID: 18779337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phagosomes are fully competent antigen-processing organelles that mediate the formation of peptide:class II MHC complexes.
    Ramachandra L; Song R; Harding CV
    J Immunol; 1999 Mar; 162(6):3263-72. PubMed ID: 10092778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficient in vivo presentation of Listeria monocytogenes- derived CD4 and CD8 T cell epitopes in the absence of IFN-gamma.
    Skoberne M; Geginat G
    J Immunol; 2002 Feb; 168(4):1854-60. PubMed ID: 11823519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phagosomes acquire nascent and recycling class II MHC molecules but primarily use nascent molecules in phagocytic antigen processing.
    Ramachandra L; Harding CV
    J Immunol; 2000 May; 164(10):5103-12. PubMed ID: 10799867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathways of MHC I cross-presentation of exogenous antigens.
    Cruz FM; Chan A; Rock KL
    Semin Immunol; 2023 Mar; 66():101729. PubMed ID: 36804685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells.
    Schreibelt G; Klinkenberg LJ; Cruz LJ; Tacken PJ; Tel J; Kreutz M; Adema GJ; Brown GD; Figdor CG; de Vries IJ
    Blood; 2012 Mar; 119(10):2284-92. PubMed ID: 22234694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternative activation of macrophages by IL-4 enhances the proteolytic capacity of their phagosomes through synergistic mechanisms.
    Balce DR; Li B; Allan ER; Rybicka JM; Krohn RM; Yates RM
    Blood; 2011 Oct; 118(15):4199-208. PubMed ID: 21846901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TLR7 triggering with polyuridylic acid promotes cross-presentation in CD8α+ conventional dendritic cells by enhancing antigen preservation and MHC class I antigen permanence on the dendritic cell surface.
    Crespo MI; Zacca ER; Núñez NG; Ranocchia RP; Maccioni M; Maletto BA; Pistoresi-Palencia MC; Morón G
    J Immunol; 2013 Feb; 190(3):948-60. PubMed ID: 23284054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salmonella infection of bone marrow-derived macrophages and dendritic cells: influence on antigen presentation and initiating an immune response.
    Yrlid U; Svensson M; Johansson C; Wick MJ
    FEMS Immunol Med Microbiol; 2000 Apr; 27(4):313-20. PubMed ID: 10727887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Signalling and phagocytosis in the orchestration of host defence.
    Blander JM
    Cell Microbiol; 2007 Feb; 9(2):290-9. PubMed ID: 17284172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficiency of antigen delivery from macrophage phagosomes into cytoplasm for MHC class I-restricted antigen presentation.
    Oh YK; Harding CV; Swanson JA
    Vaccine; 1997 Apr; 15(5):511-8. PubMed ID: 9160518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phagosomes are competent organelles for antigen cross-presentation.
    Houde M; Bertholet S; Gagnon E; Brunet S; Goyette G; Laplante A; Princiotta MF; Thibault P; Sacks D; Desjardins M
    Nature; 2003 Sep; 425(6956):402-6. PubMed ID: 14508490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.